Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Cunningham

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
JACC. Basic to Translational Science|September 10, 2025
Small Interfering RNA Therapy Targeting the Long Noncoding RNA SMILR for Therapeutic Intervention in Coronary Artery Bypass Graft FailureSimon D Brown, Anna L Malinowska, Matthew Bennett, et al.
Science (New York, N.Y.)|October 9, 2010
Genetic restoration of the Florida pantherWarren E Johnson, David P Onorato, Melody E Roelke, et al.
Antiviral Research|August 25, 2009
Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomesReginald Clayton, Asa Ohagen, Francois Nicol, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytesGang Luo, Mark Cunningham, Sean Kim, et al.
Journal of Medicinal Chemistry|September 9, 2011
Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826)David S Weinstein, Hua Gong, Arthur M Doweyko, et al.
Frontiers in Immunology|August 21, 2018
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung CancerNataly Manjarrez-Orduño, Laurence C Menard, Selena Kansal, et al.
JCI Insight|October 5, 2016
B cells from African American lupus patients exhibit an activated phenotypeLaurence C Menard, Sium Habte, Waldemar Gonsiorek, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2007
Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probePercy H Carter, Rui-Qin Liu, William R Foster, et al.
Journal of Medicinal Chemistry|November 16, 2010
Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonistsBingwei V Yang, David S Weinstein, Lidia M Doweyko, et al.
Journal of Medicinal Chemistry|April 24, 2015
Improving the pharmacokinetic and CYP inhibition profiles of azaxanthene-based glucocorticoid receptor modulators-identification of (S)-5-(2-(9-fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide (BMS-341)Michael G Yang, T G Murali Dhar, Zili Xiao, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
JACC. Basic to Translational Science|September 10, 2025
Small Interfering RNA Therapy Targeting the Long Noncoding RNA SMILR for Therapeutic Intervention in Coronary Artery Bypass Graft FailureSimon D Brown, Anna L Malinowska, Matthew Bennett, et al.
Science (New York, N.Y.)|October 9, 2010
Genetic restoration of the Florida pantherWarren E Johnson, David P Onorato, Melody E Roelke, et al.
Antiviral Research|August 25, 2009
Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomesReginald Clayton, Asa Ohagen, Francois Nicol, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytesGang Luo, Mark Cunningham, Sean Kim, et al.
Journal of Medicinal Chemistry|September 9, 2011
Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826)David S Weinstein, Hua Gong, Arthur M Doweyko, et al.
Frontiers in Immunology|August 21, 2018
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung CancerNataly Manjarrez-Orduño, Laurence C Menard, Selena Kansal, et al.
JCI Insight|October 5, 2016
B cells from African American lupus patients exhibit an activated phenotypeLaurence C Menard, Sium Habte, Waldemar Gonsiorek, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2007
Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probePercy H Carter, Rui-Qin Liu, William R Foster, et al.
Journal of Medicinal Chemistry|November 16, 2010
Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonistsBingwei V Yang, David S Weinstein, Lidia M Doweyko, et al.
Journal of Medicinal Chemistry|April 24, 2015
Improving the pharmacokinetic and CYP inhibition profiles of azaxanthene-based glucocorticoid receptor modulators-identification of (S)-5-(2-(9-fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide (BMS-341)Michael G Yang, T G Murali Dhar, Zili Xiao, et al.
Pageof 8